Page 2 - Syngene International
Syngene International rallies 13% in two days; stock nears record high
ICICI Securities expects Syngene's revenues to be back on track as the company is currently operating at 90 per cent capacity.
 "Syngene International rallies 13% in two days; stock nears record high")
After a muted Q1, Syngene guides for double-digit top line growth
But ongoing capex and depreciation may weigh on bottom line
 "After a muted Q1, Syngene guides for double-digit top line growth")
JB Chemicals & Pharma, Syngene International hit all-time highs
The stock of Syngene International has soared 24 per cent during the past month, as against a 2 per cent rise in the S&P BSE Sensex.
 "JB Chemicals & Pharma, Syngene International hit all-time highs")
Syngene International gains 5% on healthy March quarter results
The company's profit after tax rose 20 per cent to Rs 120 crore relative to last year's profit of Rs 100 crore.
 "Syngene International gains 5% on healthy March quarter results")
Syngene announces commissioning of first phase of R&D center in Hyderabad
Syngene currently operates through multiple facilities in Bengaluru spread across an area of 1.5 million square feet
 "Syngene announces commissioning of first phase of R&D center in Hyderabad")
Syngene appoints former Vodafone executive Sibaji Biswas as its CFO
Biswas will succeed incumbent CFO M B Chinappa, who will stay within the Biocon group of companies and join Biocon Biologics in a new role
 "Syngene appoints former Vodafone executive Sibaji Biswas as its CFO")
Syngene COO Manoj Nerurkar quits, to explore start-up opportunity
The announcement of the successor will be made shortly, said the company in a regulatory filing
 "Syngene COO Manoj Nerurkar quits, to explore start-up opportunity")
CEO Jonathan Hunt to join Syngene International board as whole-time director on May 1
He replaces Peter Bains, who has stepped down from company's board
Syngene International falls 5%
The company said that there was a fire last night within one of the company's laboratory building at Syngene, which has since been brought under control.
Syngene International dips over 5% after huge block deal
The stock dipped 5.5% to Rs 572 on the BSE after a more than 1% stake of the pharmaceutical company changed hands via block deal.
Syngene International hits new high on sealing deal with Strand Life Sciences
The stock rallied 9% to Rs 524, also its record high on the BSE in intra-day trade on Thursday.
Syngene International gains after starting new development center in Bangalore
The stock hit a high of Rs 494.05 and a low of Rs 477.90 so far during the day
 "Syngene International gains after starting new development center in Bangalore")
